The survival analysis of chronic severe hepatitis B with antivirus treatment
10.3760/cma.j.issn.1000-6680.2009.07.009
- VernacularTitle:慢性重型乙型肝炎抗病毒治疗的生存分析
- Author:
Guangming XIAO
;
Kaiyin HE
;
Chunliang LEI
;
Zhan YANG
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Entecavir;
Lamivudine;
Survival analysis
- From:
Chinese Journal of Infectious Diseases
2009;27(7):423-425
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse the effect of antivirus treatment on the survival time of chronic severe hepatitis B retrospectively.Methods one hundred and twenty-one patients with chronic severe hepatitis B and positive HBV DNA were divided into 3 groups:42 patients in entecavir(ETV)group,34 patients in lamivudine(LVD)group and 45 patients in control group.The primary data were recorded and followed.The survival curve was described using Kaolain-Maier method.The comparison of survival rate among groups was done using Logrank test.Results The baseline characteristics were well balanced among 3 groups.When the follow-up ended,the mean survival time of ETV group,LVD group and control group was(49.4±5.8)weeks,(51.6±6.7)weeks,(32.8±5.7)weeks;the total survival rate was 0.567,0.557,0.318 respectively,there was a statistical difference between ETV group and control grouP(χ2=5.742,P<0.05),or between LVD group and control group (χ2=5.472,P<0.05).There was not statistical difference between ETV group and LVD group in the week of 2,4,8,12,24,48.Conclusion ETV and LVD can improve the survival rate of chronic severe heoatitis B,and ETV iS not different from LVD.
